Metabolic Phenotyping Core supports autoimmune and metabolic research in Oklahoma
Official title: Metabolic Phenotyping Core
Funded at Oklahoma Medical Research Foundation · NIH-11336055 · Data updated 2026-11-12
A research center in Oklahoma is expanding a dedicated Metabolic Phenotyping Core to help scientists study how cellular metabolism relates to autoimmune diseases and other conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | February 5, 2021 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $323,950 |
| NIH project number | 2P20GM139763-06 |
| Project ID | NIH-11336055 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians in Oklahoma conducting metabolism-related studies on autoimmune diseases or related conditions who seek access to metabolic phenotyping services.
✕Less likely to help
Direct patient participation is not described; benefits are through enabling researcher-led projects that may lead to patient-facing advances.
What this research studies
This grant funds a shared core that provides advanced metabolic analysis, training, and access to state-of-the-art instruments. Researchers can use isotopic tracing, cellular respiration assessments, and metabolite profiling to understand metabolic drivers in diseases such as autoimmune conditions, cardiovascular disease, and vision loss. The center emphasizes mentorship, experimental design, and data interpretation to help investigators translate findings into future funding. The program aims to sustain core services and foster independent research within Oklahoma’s biomedical community.
Why it matters
Potential benefit: Patients could benefit from faster translation of metabolic research into new diagnostics or therapies for autoimmune and related diseases.
How similar studies have gone: Previous phases showed all RPLs obtained federal funding and expanded core usage, suggesting healthy progress and scalability for similar efforts.
Where this research is happening
-
Oklahoma Medical Research Foundation
Oklahoma City, United States Active
Researchers
- Principal investigator: Humphries, Kenneth M — Oklahoma Medical Research Foundation
- Study coordinator: Humphries, Kenneth M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.